| Variables |
N |
Mean±SD |
Minimum |
Maximum |
| Clinical and biological parameters |
| Age, years |
178 |
49±9 |
21 |
79 |
| Male gender, n(%) |
178 |
143(80) |
|
|
| BMIa, kg/m2 |
178 |
25±4 |
16 |
42 |
| Waist circumference, cm |
178 |
91±11 |
64 |
131 |
| Metabolic syndrome, n(%) |
148 |
77(52) |
|
|
| Current smokers, n(%) |
162 |
21(13) |
|
|
| Former smokers, n(%) |
162 |
59(36) |
|
|
| Anthihypertensive therapy, n(%) |
176 |
39(22) |
|
|
| Statin therapy, n(%) |
175 |
35(20) |
|
|
| Diabetics, n(%) |
178 |
9(5) |
|
|
| Total cholesterol, mmol/L |
145 |
5.33±1.01 |
2.85 |
8.55 |
| HDLb cholesterol, mmol/L |
145 |
1.26±0.44 |
0.50 |
4.40 |
| 25-hydroxyvitamin D*, ng/mL |
153 |
24 (15-34) |
5 |
68 |
| HIV-related parameters |
| Duration of PIctreatment, months* |
120 |
84 (44-171) |
0 |
361 |
| Number of patients treated with PI, n (%) |
157 |
120(76) |
|
|
| Nadir CD4 count* |
169 |
236 (90-325) |
0 |
889 |
| Current CD4 count* |
174 |
560 (402-740) |
49 |
2174 |
| Current CD8 count* |
172 |
692 (549-914) |
75 |
2101 |
| CD4/CD8 |
131 |
0.88±0.43 |
0.06 |
2.78 |
| Nadir CD4 / current CD8* |
167 |
0.339 (0.107-0.553) |
0 |
.55 |
| HIV classification: A or B, n(%) |
141 |
116(82) |
|
|
| HIV classification: C, n(%) |
141 |
25(18) |
|
|
|
